Perimenopause and Cervical Cancer: Why the Overlap Matters

The woman who never knew

In 1951, a thirty-one-year-old mother of five named Henrietta Lacks went to Johns Hopkins with vaginal bleeding she could not explain. She was diagnosed with an aggressive cervical cancer and died within months. During her treatment, a sample of her tumour was taken without her knowledge or consent, and those cells did something no human cells had done before in a laboratory. They kept dividing. They are still dividing today, in labs across the world, known as the HeLa line.

More than thirty years later, a German virologist named Harald zur Hausen was trying to prove that a virus could cause cancer. He tested the HeLa cells and found they carried multiple copies of human papillomavirus type 18. That finding, alongside his earlier work on HPV-16, established that cervical cancer has an infectious cause, and it won him the Nobel Prize in 2008. The HPV vaccines that adolescent girls in India are receiving free of charge today trace back, in a direct line, to the cells of a woman who died of the disease.

Henrietta Lacks was not careless and she was not unlucky in any way she could have controlled. She lived at a time when there was no vaccine, no HPV test and no real screening available to a woman like her. That is no longer true, and it is the entire reason this article is worth your time. Almost everything her doctors did not have, you now do.

Why cervical cancer specifically

Three things make this cancer worth singling out. The first is scale, because it remains the second most common cancer among Indian women after breast cancer, and India accounts for roughly a quarter of the world's cervical cancer deaths. The second is that it is the only major cancer that is largely vaccine-preventable, since unlike almost every other cancer it has a clear infectious cause in persistent infection with high-risk HPV. The third matters most if you are reading this in your forties: cervical cancer is almost always preceded by a detectable precancerous stage, cervical intraepithelial neoplasia, which can take years to progress into invasive disease. On average, the journey from initial HPV infection through persistence to invasive cancer takes somewhere around fifteen years.

That last point is the hopeful one. This is a slow cancer with a long warning period, and that warning period shows up on a test.

What this means for you.The window between the first detectable change and actual cancer is measured in years, not weeks, which means being a little late is usually still in time.

Can perimenopause hide cervical cancer symptoms?

Consider a woman of forty-seven whose periods have been erratic for two years. She bleeds a little after sex one evening. She mentions it at her next appointment and is told, reasonably enough, that everything about her cycle is unpredictable at the moment and that this is what perimenopause looks like. She accepts that, because it is a plausible explanation from someone who should know. Six months later the bleeding is heavier and her discharge has changed, and she almost does not raise it again, because she asked once already and was answered.

Nothing in that story is a failure of her attention. She noticed the symptom, she reported it, and she was given an explanation that fitted. The trouble is that it fitted too well, because perimenopause and early cervical change share almost the same signs. The same irregular bleeding, spotting, heavier flow, pelvic discomfort and changes in discharge can come from either one.

So the thing worth watching is not bleeding that looks abnormal in the abstract, because by this stage very little looks normal. It is bleeding that breaks from your own baseline.

The symptoms that are worth an appointment rather than a wait:

• Bleeding or spotting after sex
• Any bleeding after twelve consecutive months without a period
• Discharge that is foul-smelling, blood-tinged, or persistent
• Pelvic pain or pressure that does not resolve
• A bleeding pattern noticeably heavier, longer, or more frequent than your own usual pattern

On that second point, some precision matters. Bleeding after twelve months without a period is never simply perimenopause. Any post menopausal bleeding warrants evaluation for cervical cancer and endometrial cancer. Around ninety percent of endometrial cancers present this way. ACOG updated its guidance in April 2026 and now recommends both a transvaginal ultrasound and an endometrial biopsy for most women presenting with postmenopausal bleeding, having found that ultrasound alone misses between five and twelve percent of cancers at first evaluation.

What this means for you. You are not looking for something dramatic. You are looking for a change from your own normal, and describing that change specifically is more useful to your doctor than saying your cycle has been irregular.

How likely is cervical cancer if I have abnormal bleeding?

It is easy to read all of this and end up more frightened than informed, so here are the actual numbers. They split into two questions, because different kinds of bleeding point at different places.

If your bleeding is heavy or irregular

Here the question is mostly about the lining of the womb rather than the cervix. A systematic review of sixty-five studies covering around 29,000 premenopausal women with abnormal uterine bleeding found the risk of endometrial cancer to be 0.33 percent overall, and 0.51 percent in women aged forty to fifty. Heavy periods, which are the single most common complaint of this decade, carried the lowest risk of all at 0.11 percent, and among five studies reporting on heavy bleeding, not one identified a case of atypical hyperplasia. Bleeding between periods carried a higher risk at 0.52 percent, which is why that particular pattern earns closer attention than heaviness does.

If you bleed after sex, or between periods

This is where the cervix becomes the more relevant question. One systematic review estimated that a woman in the community aged forty-five to fifty-four who develops bleeding after sex has roughly a one in 2,400 chance of having cervical cancer. In one hospital series of women referred for colposcopy because of it, around forty percent had no cause found at all, another half had a clearly benign cause such as infection or a cervical polyp, and 0.6 percent had cervical cancer.

These numbers say two things at once. Most women in this position are perfectly fine. And the few who are not get found by the very same appointment that reassures everyone else. One visit settles it either way.

One thing to keep in mind. Most of these figures come from countries where lots of women are screened and cancers are usually caught early. In India, where fewer women are screened, more cancers are found late, so the real odds here are a little less forgiving. It does not change what you should do.

What this means for you.Heavy periods are the most common thing in this decade and carry the lowest risk of all. Bleeding after sex or between periods is the pattern that deserves a specific mention rather than a general one.

What happens after an abnormal Pap or HPV result?

This is usually the part that holds the fear, so it is worth knowing, because the actual steps are far gentler than most people picture.

An abnormal screening result is not a cancer diagnosis, and in the great majority of cases it is not even close to one. A Pap test may show cell changes; an HPV test may show a high-risk type is present. Neither means disease. The next step is usually colposcopy, which is an examination where the cervix is looked at through a magnifying instrument after a mild solution is applied to make abnormal areas visible. It takes ten to fifteen minutes, it is done in an outpatient clinic, and it does not require anaesthesia. If anything looks abnormal, a small biopsy is taken.

If that biopsy shows precancerous change, treatment is also an outpatient procedure. The most common options are a loop excision, which removes the affected tissue with a fine wire loop under local anaesthetic, or ablation using heat or cold to destroy the abnormal cells. These take roughly fifteen to twenty minutes. Reported cure rates sit between ninety and ninety-eight percent depending on the method and the grade of the lesion, and cryotherapy has not been shown to affect later pregnancy rates.

So the woman of forty-seven. She did raise it again, and this time she described the specific thing, which was bleeding after sex rather than an irregular cycle in general. She was referred for colposcopy, a biopsy showed high-grade precancer, and it was treated in a single outpatient visit. She did not have cancer and now she is not going to get it. The only thing that changed her outcome was saying the specific sentence out loud a second time.

What this means for you. An abnormal result is not a cancer diagnosis. Precancer is treated in one short outpatient appointment, and treating it cuts the thirty-year cancer risk from roughly thirty-one percent down to under one percent.

Why does cervical cancer risk rise during perimenopause?

There is a biological reason this age window matters beyond the symptom overlap. Most women clear HPV on their own within about two years of infection, and it is persistence of high-risk types rather than the initial infection that drives progression toward precancer. The perimenopausal transition happens to coincide with measurable shifts in immune function. Declining oestrogen is associated with reduced cytotoxic T-cell and natural killer cell activity, thinning of the genital tract lining, and changes in the vaginal microbiome including a fall in protective Lactobacillus species. Each of these has been independently linked to a reduced ability to clear HPV, or to reactivation of infections that had lain dormant for years.

So a woman who tested negative or cleared an infection in her twenties or thirties is not necessarily settled for life. None of this is a consequence of anything she did. It is the ordinary immunology of this stage.

What this means for you.A clean result years ago does not retire you from screening, and this second window opens through no fault of yours.

How often should I get screened for cervical cancer in India?

For Indian clinical practice, ICMR guidance is that women aged thirty and above should have a Pap test once every three years until sixty-five, and that the interval can extend to five years when the Pap is combined with an HPV test. That is what most gynaecologists in private practice follow, and it is reasonable, accessible advice today.

There is one more development worth knowing about, and it speaks directly to the most common reason women skip this. For a great many women the barrier has never been ignorance or indifference. It is the speculum, the examination table, the discomfort and the lack of privacy in a crowded clinic, and those are legitimate reasons rather than excuses. Self-sampling was designed for precisely this. The European Union recommendation explicitly includes offering kits that let a woman collect her own sample, and the World Health Organization supports self-collection as a route to its seventy percent screening target. An indigenous Indian kit, CERVICHECK, has been clinically evaluated and approved by the Drugs Controller General of India, with agreement against clinician-collected samples above ninety-five percent for high-risk HPV. Indian field studies have reported acceptance rates above ninety-eight percent once women were given basic information about the test, and states including Sikkim have piloted home-based self-sampling. It is not yet standard care nationally, but it exists, and it is worth asking your gynaecologist about.

What this means for you.Ask for a Pap test every three years from age thirty, or an HPV test every five years if you can access one. If the examination itself is what has kept you away, ask specifically about self-sampling.

Why this first step is yours to take

In many countries, a woman gets a letter in the post when she is due for screening, and the system does the remembering for her. India is not set up that way yet. Here, screening mostly happens when a woman decides to ask for it, and by the last national survey only 1.9 percent of Indian women had ever been screened at all. That number is not about how much women care about their health. It is about a system that does not yet reach out to each of them by name.

India did take a real step in February 2026, launching its first free HPV vaccination campaign for girls aged fourteen, and over the coming decades that will change the picture. For anyone already past that age, though, it does not help, and the good news is that you do not need it to. The first move is a small one and it is fully within your hands: one conversation with your gynaecologist is enough to begin.

What this means for you.In India, screening usually begins with you asking for it. That is a small thing to do, and it is the single step that puts you ahead of the odds.

Is HPV vaccination still relevant at this age?

Vaccination is not only a conversation for teenagers, though the honest answer for an adult woman is more qualified than most people expect. In India the approved vaccines, meaning Cervavac, Gardasil and Cervarix, carry official label approval for ages nine through twenty-six. For women past twenty-six who were never vaccinated there is no formal national guideline, and the national campaign does not cover them. Vaccination beyond the labelled age range is a private, physician-guided decision that depends on your own exposure history and risk profile.

What this means for you.Worth raising with your gynaecologist, and worth understanding as an addition to screening rather than a substitute for it. If you have a daughter approaching fourteen, the national campaign is free and she is eligible.

A few things worth setting straight

Years of normal results do not retire you from screening, because this decade opens the risk back up. Being no longer sexually active does not exempt you either, since an old HPV infection can persist or come back years later. And screening is not just for younger women. Both the number of cases and the number of deaths rise with age, which is exactly why the guidelines run all the way to sixty-five.

If you read nothing else

1. Work out when you were last screened. If you cannot remember, that is your answer and it is worth booking.
2. Notice whether anything about your bleeding has changed from your own recent pattern, particularly bleeding after sex or between periods, and mention that specific pattern rather than describing your cycle as generally irregular.
3. If any bleeding has occurred after twelve months without a period, treat that as its own appointment rather than folding it into a routine visit.
4. If the examination is what has stopped you before, ask about HPV self-sampling by name.

Perimenopause is a real and disruptive transition, and it deserves attention on its own terms. It just should not become the thing that quietly explains away everything else. If you have spent this decade being told that what you feel is only hormones, you are not imagining the pattern, and asking one more specific question is a completely reasonable thing to do. With this particular cancer, doing that in time is almost always enough.

References

1. Avsaroglu E, Kaleli B, Kilic D, Kaleli I, Guler T. A Decrease in Lactobacilli in the Vaginal Microbiota Is Independently Associated With HPV Persistence in Women With High-Risk HPV Infection. Cureus. 2023;15(12):e50907.
2. Ramamoorthy T, Kulothungan V, Sathishkumar K, et al. Burden of cervical cancer in India. Reprod Health. 2024;21(1):111. PMID: 39075548
3. Grover A, Dhanasekaran K, et al. Cervical cancer burden in India: A descriptive epidemiological study and policy insights. Glob Epidemiol. 2025;10:100233.
4. Maheshwari A, Kumar N, Mahantshetty U. Gynecological cancers: A summary of published Indian data. South Asian J Cancer. 2016;5(3):112-120. PMID: 27606294
5. Pennant ME, Mehta R, Moody P, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG. 2017;124(3):404-411. (source of the 0.33%, 0.51% and 0.11% figures)
6. Shapley M, Jordan J, Croft PR. A systematic review of postcoital bleeding and risk of cervical cancer. Br J Gen Pract. 2006;56(527):453-460. PMID: 16762128 (source of the 1 in 2,400 figure)
7. McCredie MRE, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425-434. (source of the 31.3% versus 0.7% comparison)
8. Santesso N, Mustafa RA, Wiercioch W, et al. / IARC. Treatment of cervical intraepithelial neoplasia: cure rates for LLETZ, cryotherapy and thermal ablation. In: Colposcopy and Treatment of Cervical Precancer, IARC Technical Report. NCBI Bookshelf NBK568369.
9. Ranganathan P, et al. Status of cancer screening in India: An alarm signal from the National Family Health Survey (NFHS-5). J Family Med Prim Care. PMID: 36992989 (source of the 1.9% figure)
10. Shastri SS, Mittra I, Mishra GA, et al. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst. 2014;106(3):dju009. PMID: 24563518
11. Ministry of Health and Family Welfare, Government of India. Operational Framework: Management of Common Cancers, 2016. Carried forward under NP-NCD Operational Guidelines 2023–2030.
12. ICMR – National Institute of Cancer Prevention and Research. Cervical cancer screening guidance. cancerindia.org.in
13. IARC / European Commission Initiative on Cervical Cancer Expert Working Group. First recommendations for cervical cancer screening in the European Union, July 2025.
14. Council Recommendation of 9 December 2022 on strengthening prevention through early detection (OJ C 473, 13.12.2022).
15. World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: WHO; 2020.
16. Press Information Bureau, Government of India. National HPV Vaccination Programme (campaign launched 28 February 2026).
17. Performance of HPV Self-Sample Collected by a Novel Kit (CERVICHECK) in Comparison with Clinician Collected Sample. PMC12008359.
18. American College of Obstetricians and Gynecologists. Updated Guidance Regarding the Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding. Obstet Gynecol. 2026 Apr 16. PMID: 41990335
19. Skloot R. The Immortal Life of Henrietta Lacks. Crown; 2010. (zur Hausen received the Nobel Prize in Physiology or Medicine, 2008.)

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your health.